8 completed, 4 not yet recruiting, 2 recruiting, 2 unknown. 7 Not applicable, 5 Phase 2, 5 Phase 3, 2 Phase 1, 1 Phase 4.
Follow Sickle Cell Anemia in Children: new trials by email Literature Review of Sickle Cell Anemia in Children trials Research Report on Sickle Cell Anemia in Children
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease Individuation and Perspective-Taking (IPT), pediatric SCD pain management education session - Sickle Cell Disease, Sickle Cell Anemia in Children | Not applicable | Not yet recruiting | Connecticut Children's Medical Center | 30 | 2027-09-01 | 2026-04-29 |
| Buprenorphine for the Management of Pain in Children With Sickle Cell Disease Buprenorphine Buccal Film [Belbuca] - Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis | Phase 1 | Not yet recruiting | Natasha Archer | 25 | 2027-01-01 | 2026-11-04 |
| Hypoxic Red Blood Cells in Sickle Cell Anemia Hemanext ONE System, Conventional RBCs - Sickle Cell Anaemia, Sickle Cell Anemia Crisis | Not applicable | Not yet recruiting | Hemanext | 48 | 2026-11-30 | 2026-11-02 |
| Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease video intervention, game intervention - Sickle Cell Anemia in Children | Not applicable | Not yet recruiting | Aula Ibrahim abd alrazak | 120 | 2026-09-01 | 2026-09-03 |
| Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study hydroxycarbamide - Sickle Cell Disease, Sickle Cell Anemia in Children | Phase 1 / Phase 2 | Recruiting | Children's Hospital Medical Center, Cincinnati | 250 | 2026-05-13 | 2026-07-16 |
| Effect of Aquatic Exercises on Muscle Strength and Quality of Life in Children With Sickle Cell Anemia aquatic exercise in addition to physical exercise, designed physical exercises only - Sickle Cell Anemia in Children | Not applicable | Completed | Kafrelsheikh University | 50 | 2025-11-01 | 2026-01-06 |
| Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa Hydroxyurea - Sickle Cell Anemia in Children, Sickle Cell Disease | Phase 3 | Recruiting | Brown University | 400 | 2023-11-15 | 2026-08-20 |
| Low Systemic/High Local Exercise Load in Peds SCD Low systemic strength training, Moderate systemic exercise - Sickle Cell Anemia in Children | Not applicable | Unknown | University of Mississippi Medical Center | 60 | 2023-09-19 | 2024-04-29 |
| The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia Voxelotor - Sickle Cell Anemia in Children | Phase 2 | Terminated | Emory University | 22 | 2022-03-28 | 2025-12-12 |
| Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia Dihydroartemisinin Piperaquine - Sickle Cell Anemia in Children, Malaria | Phase 3 | Completed | Liverpool School of Tropical Medicine | 723 | 2021-04-09 | 2023-09-13 |
| Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda ( BRAINSAFE-II ) Hydroxyurea - Sickle Cell Anemia in Children | Phase 3 | Completed | Global Health Uganda LTD | 270 | 2021-03-09 | 2025-04-17 |
| The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria This study does not entail offering any intervention; all data collected will be based on standard of care. - Sickle Cell Disease, Stroke | Completed | Vanderbilt University Medical Center | 350 | 2020-04-01 | 2024-04-23 | |
| Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients Acacia Senegal extract, Pectin - Sickle Cell Anemia in Children | Phase 2 / Phase 3 | Unknown | Al-Neelain University | 100 | 2020-02-15 | 2020-01-28 |
| Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia Omega 3, Vit D, Zinc sulfate - Vaso-occlusive Crisis, Sickle Cell Disease | Phase 2 / Phase 3 | Completed | Beni-Suef University | 350 | 2019-11-01 | 2021-01-27 |
| Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE) Hydroxyurea, Elevated Arm TCD Examination, Normal Arm TCD Examination - Sickle Cell Anemia in Children | Phase 2 | Active not recruiting | Children's Hospital Medical Center, Cincinnati | 202 | 2019-04-24 | 2026-10-19 |
| PINPOINT: Gaming Technology for SCD Pain Pinpoint app - Sickle Cell Disease, Sickle Cell Anemia in Children | Not applicable | Completed | Klein Buendel, Inc. | 24 | 2018-09-19 | 2024-05-01 |
| A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT Vitamin D3, Standard Vitamin D3 Supplementation - Vitamin D Deficiency, Stem Cell Transplant Complications | Phase 4 | Completed | Phoenix Children's Hospital | 49 | 2017-11-01 | 2020-11-17 |
| Nutritional Outcomes After Vitamin A Supplementation in Subjects With SCD retinyl palmitate - Sickle Cell Anemia in Children, Vitamin A Deficiency in Children | Not applicable | Completed | Children's Hospital of Philadelphia | 42 | 2015-10-02 | 2018-08-16 |
Anemia, Sickle Cell (11) · Vaso-Occlusive Crises (3) · Stroke (2) · Acute Pain (1) · Anemia, Aplastic (1) · Hematologic Diseases (1) · Hemoglobin SC Disease (1) · Malaria (1) · Myelodysplastic Syndromes (1) · Neoplasms (1) · Neurologic Manifestations (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Vitamin D Deficiency (1) · beta-Thalassemia (1)
Anemia (12) · Hemic and Lymphatic Diseases (12) · Anemia, Hemolytic (11) · Anemia, Hemolytic, Congenital (11) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (11) · Genetic Diseases, Inborn (11) · Hematologic Diseases (11) · Hemoglobinopathies (11) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
Hydroxyurea (5) · Buprenorphine (1) · Cardiovascular Agents (1) · Cholecalciferol (1) · Docosahexaenoic Acids (1) · Gum Arabic (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Morphine (1) · Pectins (1) · Simvastatin (1) · Zinc Sulfate (1) · retinol palmitate (1) · voxelotor (1)
Children's Hospital Medical Center, Cincinnati (2) · Al-Neelain University (1) · Aula Ibrahim abd alrazak (1) · Beni-Suef University (1) · Brown University (1) · Children's Hospital of Philadelphia (1) · Connecticut Children's Medical Center (1) · Emory University (1) · Global Health Uganda LTD (1) · Hemanext (1) · Kafrelsheikh University (1) · Klein Buendel, Inc. (1) · Liverpool School of Tropical Medicine (1) · Natasha Archer (1) · Phoenix Children's Hospital (1)
United States (10) · Uganda (3) · Egypt (2) · Angola (1) · Iraq (1) · Malawi (1) · Nigeria (1) · Saudi Arabia (1) · Sudan (1) · Tanzania (1)
Ahmed F Mahmoud Hussein, MS.c (1) · Alexander Ngwube, MD (1) · Amy Tang, MD (1) · Biree Andemariam, MD (1) · Imad M Fdl-Elmula, PhD (1) · Kayla Burgett (1) · Laurel Omert, MD, FACS (1) · Michael R DeBaun, MD, MPH (1) · Nancy Green, MD (1) · Natasha Archer, MD (1) · Patrick T McGann, MD, MS (1)
PMID 33305842, PMID 33875811, PMID 35911824, PMID 36870358, PMID 37016392, PMID 37468045, PMID 38364110, PMID 39717517, PMID 39718172, PMID 40085947
K23HL175237 (1), R01HD096559 (1), R44MD010746 (1), U01HL157872 (1)